Sponsor:
AHS Cancer Control Alberta
Code:
NCT05358262
Conditions
Autologous Stem Cell Transplant
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Airvo
Standard of Care
Brief summary:
Conditions
Autologous Stem Cell Transplant
Study ID
NCT05358262
Start date
Nov 5, 2024
Status verified date
Jan, 2025
Completion date
Jan, 2026
Anticipated
Primary completion date
Jan, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
90 participants
Anticipated
Allocation
Randomized
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Intervention using the Airvo device
active comparator: Standard of Care
Interventions
Airvo
Standard of Care
Primary outcome measure
Central contacts
Locations
Cross Cancer Institute
Recruiting
Edmonton, Alberta, Canada, T6G 1Z2
Contacts
Sponsor
AHS Cancer Control Alberta
Last update posted
Jan 30, 2025
Last verified
Jan, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by AHS Cancer Control Alberta on 2025-01-30.